...
首页> 外文期刊>World Journal of Gastroenterology >Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: A prospective study.
【24h】

Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: A prospective study.

机译:丙型肝炎病毒相关肝病的严重程度与肝脏中幽门螺杆菌种类之间的关系:一项前瞻性研究。

获取原文
获取原文并翻译 | 示例

摘要

AIM: To determine the presence of Helicobacter species DNA in the liver of chronic hepatitis C (CHC) patients with and without cirrhosis as compared to controls, and to identify the bacterial species involved. METHODS: Seventy-nine consecutive patients (HBV and HIV negative) with a liver sample obtained after liver biopsy or hepatic resection were studied: 41 with CHC without cirrhosis, 12 with CHC and cirrhosis, and 26 controls (HCV negative). Polymerase chain reactions (PCRs) targeting Helicobacter 16S rDNA and species-specific were performed on DNA extracted from the liver. A gastric infection with H pylori was determined by serology and confirmed by (13)C-urea breath test. RESULTS: Overall, Helicobacter 16S rDNA was found in 16 patients (20.2%). Although positive cases tended to be higher in CHC patients with cirrhosis (41.6%) than in those without cirrhosis (17.0%) or in controls (15.4%), the difference was not statistically significant (P = 0.08). H pylori-like DNA was identified in 12 cases and H. pullorum DNA in 2, while 2 cases remained unidenti-fied. Gastric infection with H pylori was found in only 2 of these patients. CONCLUSION: Our results do not confirm the associ-ation of Helicobacter species DNA in the liver of CHC patients with advanced liver disease. The lack of correlation between positive H pylori serology and the presence of H pylori-like DNA in the liver may indicate the presence of a variant of this species.
机译:目的:确定与对照组相比有或无肝硬化的慢性丙型肝炎(CHC)患者肝脏中幽门螺杆菌DNA的存在,并鉴定涉及的细菌种类。方法:对79例连续活检或肝切除术后获得肝样本的患者(HBV和HIV阴性)进行了研究:41例无肝硬化的CHC,12例肝硬化和肝硬化的患者和26例对照(HCV阴性)。针对从肝脏提取的DNA进行了针对幽门螺杆菌16S rDNA且具有物种特异性的聚合酶链反应(PCR)。通过血清学确定胃幽门螺杆菌感染,并通过(13)C-尿素呼气试验证实。结果:总体上,在16例患者中发现了Helicobacter 16S rDNA(20.2%)。尽管有肝硬化的CHC患者中阳性病例的比例(41.6%)比没有肝硬化的CHC患者中的阳性病例(15.4%)更高,但差异无统计学意义(P = 0.08)。在12例中鉴定出H样幽门螺杆菌DNA,在2例中鉴定出白痢菌DNA,而2例仍未鉴定。在这些患者中只有2例发现胃感染有幽门螺杆菌。结论:我们的结果并未证实晚期肝病CHC患者肝脏中幽门螺杆菌DNA的关联。阳性幽门螺杆菌血清学与肝脏中存在幽门螺杆菌样DNA之间缺乏相关性,这可能表明该物种存在变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号